| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5135943 | LACER PHARMA | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
May, 2014
(9 years ago) | |
Ertaczo is owned by Lacer Pharma.
Ertaczo contains Sertaconazole Nitrate.
Ertaczo has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Ertaczo are:
- US5135943
Ertaczo was authorised for market use on 10 December, 2003.
Ertaczo is available in cream;topical dosage forms.
Ertaczo can be used as product is approved for the topical treatment of tinea pedis.
The generics of Ertaczo are possible to be released after 31 May, 2014.
Drugs and Companies using SERTACONAZOLE NITRATE ingredient
Market Authorisation Date: 10 December, 2003
Treatment: Product is approved for the topical treatment of tinea pedis
Dosage: CREAM;TOPICAL
More Information on Dosage
ERTACZO family patents
